• »
  • Alpha Lipoic Acid - Introducing the potent, protective antioxidant which helps to promote healthy blood sugar levels

Alpha Lipoic Acid - Introducing the potent, protective antioxidant which helps to promote healthy blood sugar levels

According to the International Diabetes Foundation, 382 million people have diabetes. If that number doesn't surprise you, consider that diabetes diagnoses will climb to 592 million by 2035. Cases of type 2 diabetes are increasing in every country.

More than ever, it's important to find natural resources to support healthy blood sugar levels and protect the body against oxidative stress. In what is called metabolic syndrome — referring to risk factors like high blood pressure, high triglycerides, insulin resistance and low HDL - the risk of both diabetes and heart disease increases dramatically.

ONE ANTIOXIDANT PROMOTES HEALTHY BLOOD SUGAR LEVELS

Supplementing with the right antioxidant can keep blood sugar levels stable. Alpha lipoic acid (ALA) is a potent, protective antioxidant with benefits to:

  • Reduce oxidative stress
  • Maintain optimal blood sugar levels
  • Help the body better use glucose
  • Support insulin sensitivity
  • Improve endothelial function
  • Enhance eye health 1
  • Protect against Alzheimer's disease 2
  • Prevent bones loss 3

And the list goes on. Many health professional now understand that Alpha lipoic acid is critical to support healthy blood sugar levels. Within the spectrum
of metabolic syndrome, alpha lipoic acid has the ability to relieve a number of major risk factors that contribute to prediabetes. Research supports that patients with metabolic syndrome can use alpha lipoic acid to balance blood pressure and insulin resistance, improve their lipid profile and maintain a healthy weight 4

Patients that have already been diagnosed with type 2 diabetes can still benefit from all ALA has to offer. Research backs alpha lipoic acid in the treatment of nerve damage associated with high blood sugar levels in diabetics, also called diabetic neuropathy.5

BIO ENHANCED ALPHA LIPOIC ACID R IS A CUT ABOVE

If you're looking for the protective antioxidant benefits of alpha lipoic acid — and especially if you have metabolic syndrome or type 2 diabetes you have a decision to make When choosing a supplement you're likely to find the free acid' form of lipoic acid: R-Lipoic Acid (RLA). Unfortunately, RLA is not as bioavailable as the alternative ALA R, or Alpha Lipoic AcidTM.

ALA R has a maximum plasma concentration 40 times higher than unstabilised PLA. according to research conducted in a preliminary triaL Bioenhanced ALA R also comes with a long list of added benefits - quicker release and zero risk of heartburn and indigestion, to name a few Research supports lipoic acid as a pivotal tool in the rehabilitation of metabolic syndrome and type 2 diabetes. But the type of alpha lipoic acid that you take does matter. The network antioxidant Alpha Lipoic Acid RTM can balance blood sugar and support eye, pancreas and liver health. ALA R taken as a supplement can even improve the absorption of other supplements, making them more effective.

RECOMMENDED PRODUCTS

ALPHA LIPOIC ACID R TM

Simply the best form of ALA available.

Alpha Lipoic Acid

 

References:

1 Maitro I, Serbinova E, Trischler H, Packer L Alpha lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Radic Biol Med. 1995 Apr:18(4)823-9.

2 Holmquist L, C Stuchbury G,  Berbaum K et at Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol. Ther. 2007 Jan: 1 13(1):154-64.

3. Ha H, Lee .JH, Kym HN et al Alpha lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J Immunol. 2006 1:176(1):111-7.

4. Pershadsingh HA, Alpha lipoic acid physiologic mechanisms and indications for the treatment of metabolic syndrome. Expert Opin Investig Drugs. 2007 Mar:16(3):291-302

5. Ziegler D, Hanefield M, Ruhanau KJ, et al Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3 week multicentre randomized controlled trial (ALADIN Study). Diabetologia, 1995 Dec:38(12):1425-33.